Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Osteogenesis imperfecta (OI) is a genetic bone pathology with prenatal onset, characterized by brittle bones in response to abnormal collagen composition. There is presently no cure for OI. We previously showed that human first trimester fetal blood mesenchymal stem cells (MSCs) transplanted into a...
Main Authors: | Jones, G, Moschidou, D, Abdulrazzak, H, Kalirai, B, Vanleene, M, Osatis, S, Shefelbine, S, Horwood, N, Marenzana, M, De Coppi, P, Bassett, J, Williams, G, Fisk, N, Guillot, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2014
|
פריטים דומים
-
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells
מאת: Jones, G, et al.
יצא לאור: (2012) -
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
מאת: Vanleene, M, et al.
יצא לאור: (2011) -
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells.
מאת: Gemma N Jones, et al.
יצא לאור: (2012-01-01) -
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
מאת: Guillot, P, et al.
יצא לאור: (2008) -
Structure–mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model
מאת: Andriotis, O. G., et al.
יצא לאור: (2016)